SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-139198
Filing Date
2021-11-15
Accepted
2021-11-15 16:21:17
Documents
66
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q acur-20210930x10q.htm   iXBRL 10-Q 1646003
2 EXHIBIT 31.1 acur-20210930xex31d1.htm EX-31.1 13359
3 EXHIBIT 31.2 acur-20210930xex31d2.htm EX-31.2 13769
4 EXHIBIT 32.1 acur-20210930xex32d1.htm EX-32.1 10448
  Complete submission text file 0001104659-21-139198.txt   6899325

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA acur-20210930.xsd EX-101.SCH 48315
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acur-20210930_cal.xml EX-101.CAL 43042
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acur-20210930_def.xml EX-101.DEF 219479
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE acur-20210930_lab.xml EX-101.LAB 401381
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acur-20210930_pre.xml EX-101.PRE 338954
10 EXTRACTED XBRL INSTANCE DOCUMENT acur-20210930x10q_htm.xml XML 1239157
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10113 | Film No.: 211411022
SIC: 2834 Pharmaceutical Preparations